Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
G3-YSD CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
Recombinant human IFN-γ CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
Ionomycin CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
STING inhibitor CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
Mouse Control IgG2a CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
2'3'-cGAMP CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell... 2024 Cell Mol Immunol. Lei X. et al. DOI: 10.1038/s41423-024-01133-1
LPS-EB VacciGrade™ Vitamin A deficiency impairs neutrophil-mediated control of Salmonella via SL... 2024 Nat Microbiol. Lokken-Toyli K.L. et al. DOI: 10.1038/s41564-024-01613-0
Normocin™ - Antimicrobial Reagent Single-cell and spatial multi-omics highlight effects of anti-integrin therap... 2024 Nat Commun. Mennillo E. et al. DOI: 10.1038/s41467-024-45665-6
ODN 1826 - TLR9 ligand Reduction in creatine metabolites in macrophages exposed to small molecule an... 2024 Parasite Immunol. Alanazi S. et al. DOI: 10.1111/pim.13026
Primocin® Interplay in galectin expression predicts patient outcomes in a spatially res... 2024 Biomed Pharmacother. Abudu O. et al. DOI: 10.1016/j.biopha.2024.116283
pFUSE2-CLIg-hK ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants:... 2023 Antib Ther. Alfaleh M.A. et al. DOI: 10.1093/abt/tbad030
Anti-hIL-6 Neutralizing mAb Importance of IL-6 trans-signaling and high autocrine IL-6 production in huma... 2024 Osteoarthritis Cartilage Eitner A. et al. DOI: 10.1016/j.joca.2024.02.006
Plasmocin® - Mycoplasma Elimination Reagent Molnupiravir inhibits human norovirus and rotavirus replication in 3D human i... 2024 Antiviral Res. Santos-Ferreira N. et al. DOI: 10.1016/j.antiviral.2024.105839
Puromycin Nuclear RNA-related processes modulate the assembly of cytoplasmic RNA granules. 2024 Nucleic Acids Res. Angel M. et al. DOI: 10.1093/nar/gkae119
Blasticidin Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380
Zeocin® Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380
B16-Blue™ IFN-α/β Cells Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380
IFN-α/β Reporter HEK 293 Cells Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380
Normocin™ - Antimicrobial Reagent Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380
QUANTI-Blue™ Increased type-I interferon level is associated with liver damage and fibrosi... 2024 Hepatol Commun. Salzmann R.J.S. et al. DOI: 10.1097/HC9.0000000000000380

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty